Trump pressures 17 pharma CEOs to cut US drug prices Reuters Trump Demands That Drugmakers Lower Some of Their U.S. Prices by September The New York Times Trump’s drug price ultimatum sets pharma firms scrambling CNBC Trump calls for price cuts on prescription drugs within 60 days in letters to Eli Lilly, Pfizer, other drugmakers NBC News Trump threatens drug giants with crackdown over …
Read More »Tag Archives: Pharma
Moderna, working through operating cost and R&D cuts, to sideline 10% of global workforce by year-end – Fierce Pharma
Moderna, working through operating cost and R&D cuts, to sideline 10% of global workforce by year-end Fierce Pharma Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow CNBC Moderna will lay off 10% of employees, Massachusetts-based company announces CBS News Vaccine maker Moderna cuts hundreds of jobs; CEO says ‘every effort’ made to avoid layoffs The Business Journals Moderna …
Read More »Trump is demanding drugmakers lower prices within 60 days. Pharma experts say it’s unlikely to happen.
Prescription drugs Donald Trump Health care policy Tariffs See all topics Facebook Tweet Email Link President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ones available to patients in other countries — though industry experts don’t expect the pharmaceutical companies to acquiesce. Trump sent letters to 17 …
Read More »Vinay Prasad departs FDA amid conservative criticism, controversy over Sarepta gene therapy – Fierce Pharma
Vinay Prasad departs FDA amid conservative criticism, controversy over Sarepta gene therapy Fierce Pharma Trump drove firing of FDA official Politico Are we sure Vinay Prasad’s ouster is positive for biotech? statnews.com FDA’s Prasad Exits Following Political Backlash Over Sarepta Bloomberg.com FDA’s top vaccine official leaves post after less than four months The Guardian Source link
Read More »Exclusive | KKR Pushes Further Into Healthcare With Deal for Pharma Royalty Business – The Wall Street Journal
Exclusive | KKR Pushes Further Into Healthcare With Deal for Pharma Royalty Business The Wall Street Journal KKR Pushes Further Into Healthcare With Deal for Pharma Royalty Business Yahoo Finance KKR & Co. Acquires Majority Ownership Stake In HCRx Nasdaq KKR buys HealthCare Royalty Partners as firm deepens bet on life sciences Endpoints News KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the …
Read More »Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 – Fierce Pharma
Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 Fierce Pharma Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook CNBC Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop Investor’s Business Daily Merck to Lay Off Workers and Narrows Guidance as Earnings Fall – WSJ The Wall Street Journal Our Q2 2025 financial results Merck.com …
Read More »AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh
The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images AstraZeneca on Monday said it plans to invest $50 billion in bolstering its U.S. manufacturing and research capabilities by 2030, becoming the latest pharmaceutical firm to ramp up its stateside spending in the wake of U.S. trade tariffs. The Anglo-Swedish biotech company, which is headquartered …
Read More »Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion – Fierce Pharma
Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion Fierce Pharma BMS’ Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial BioSpace Bristol Myers Squibb’s Reblozyl fails Phase 3 in anemia; Sanofi, Blueprint deal closes Endpoints News Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here’s What Investors Are Thinking Stocktwits Luspatercept Plus …
Read More »